Joined September 2009
Krishna Chinthalapudi retweeted
What the industry is hiding about nicotine pouches: ☠️ Addictive: designed to hook you fast 🧪 Toxic: unregulated levels of nicotine ❤️ Increased risk of cardiovascular disease 🧠 Damages brain development No smoke. No smell. No warning. Around 160 countries have NO specific regulations for nicotine pouches. The industry is exploiting every gap. It's time to expose them. #TobaccoExposed
Readers added context they thought people might want to know
Unverified claims made- Slower nicotine delivery, lower abuse liability: pubmed.ncbi.nlm.nih.gov/34432106/ fda.gov/news-events/pr… FDA authorised 20 ZYN products after extensive scientific review: accessdata.fda.gov/static/searcht… tobaccocontrol.bmj.com/content/tobacc… Cardiovascular effects comparable to never-smokers: sciencemediacentre.org/expert-reactio… pubmed.ncbi.nlm.nih.gov/41882592/ Brain structural differences; no causal harm established in humans: jamanetwork.com/journals/jaman… ash.org.uk/resources/view…
46
73
14
148
64,862
Krishna Chinthalapudi retweeted
Very pleased that after a rigorous (and lengthy) review process, our paper visualizing how myosin generated forces modulate actin filament structure for mechanosensitive recogntion by α-catenin has appeared in @Nature nature.com/articles/s41586-0…
4
24
2
91
7,382
Krishna Chinthalapudi retweeted
Basic Experimental Studies in Humans (BESH) Will No Longer Be Considered Clinical Trials by the NIH grants.nih.gov/grants/guide/…
7
29
5
110
26,423
Krishna Chinthalapudi retweeted
Vought has ordered a halt on all extramural NIH funding for the rest of the FY. No words. You cannot let this stand @SenateDems @SenateGOP @NIHDirector_Jay @hubermanlab wsj.com/politics/policy/trum… Trump Administration Puts New Chokehold on Billions in Health-Research
12
91
11
225
24,159
Krishna Chinthalapudi retweeted
We are walking the Ullswater Way with @OscarsCharity in May. Learn more and donate here: justgiving.com/team/thalia #braintumours #childhoodcancer #cancer
1
5
1
37
4,894
Krishna Chinthalapudi retweeted
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases. I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known. People can contact me directly at my first name (as written in my profile) at octant.bio.
977
5,232
205
18,771
2,658,024
I’m looking for a motivated postdoc to join my lab with a structural biology background. Reach out to me if you are interested in the structure-function studies of actin cytoskeleton and membrane repair processes.
1
6
4
829
Krishna Chinthalapudi retweeted
Replying to @CellAdhesion
@CellAdhesion @Heissler_Lab report the structure of dysferlin, offering insights into its molecular mechanisms and how mutations impair its function #dysferlin #membrane_repair nature.com/articles/s41467-0…
1
3
7
421
Our work on membrane repair protein dysferlin is published in Nature Communications. Very proud of the team. rdcu.be/dZuag
2
1
1
11
848
Cryo-EM structures of cardiac muscle α-actin mutants M305L and A331P g... sciencedirect.com/science/ar… Our work on cardiac actin mutants A331P and M305L is now published. Great collaboration with @Heissler_Lab @SPOREMOHAN labs.
4
14
792
Krishna Chinthalapudi retweeted
Another beautiful collaboration with @Heissler_Lab and @CellAdhesion Structure and analysis of HCM causing actin mutations ACTC1 M305L and A331P sciencedirect.com/science/ar…
1
11
995